R&G PharmaStudies Co., Ltd. approved the cash dividend of CNY 2.50 (tax included) per 10 shares for the year 2022, at the AGM held on May 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.68 CNY | -0.33% | -9.41% | -38.46% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.46% | 528M | |
+24.66% | 88.22B | |
-21.76% | 76.5B | |
+1.76% | 26.97B | |
+7.94% | 18.61B | |
-13.50% | 16.72B | |
+3.23% | 15.85B | |
+77.51% | 13.41B | |
+76.96% | 13.16B | |
+23.02% | 12.67B |
- Stock Market
- Equities
- 301333 Stock
- News R&G PharmaStudies Co., Ltd.
- R&G Pharmastudies Co., Ltd. Approves the Cash Dividend for the Year 2022